This Week in Sleep Medicine: September 26, 2016
Your media watchdog for headlines and trends
relevant to sleep technology and patient education.
“Sleep is key to curing chronic pain”
September 21, 2016
From the article: “ ‘I won't be able to cope with my pain if I don't sleep well.’ Based on this complaint, new research from the University of Warwick reveals that the way chronic pain patients think about pain and sleep leads to insomnia and poor management of pain.”
Takeaway: We all have pain patients… either it’s due to arthritis or neuropathy or other factors. Here’s an interesting discussion about the companion problems of poor sleep and pain management. There are some good arguments here to tuck into your back pocket for those patients who resist CPAP to treat underlying and newly diagnosed OSA as well… if they want to feel better, they need to do more than treat their pain, but their sleep breathing disorder, as well.
“Study Quantifies Prevalence, Sensitivity, Specificity of PSG SOREMP for Narcolepsy”
August 26, 2016
From the article: “In what researchers describe as the first study to evaluate the prevalence of short onset rapid eye movement period (SOREMP) latency, an unexpected finding was revealed.”
Takeaway: These are pretty interesting results and show how research is still necessary to fully understand how narcolepsy is diagnosed. For now, we have MSLTs, but new protocols could develop in the future.
“Adult Obesity Prevalence Maps”
CENTERS FOR DISEASE CONTROL AND PREVENTION
September 2, 2016
From the article: “Obesity Prevalence in 2015 Varies Across States and Territories”
Takeaway: Lots of good data here to provide a snapshot of obesity trends in the US, which are usually strongly tied to sleep disorders, especially sleep apnea. If your lab is situated in an area that has a higher-than-average obesity risk, it may be worth it to develop some patient education materials to help them understand the connection between obesity and sleep disorders.
“U.S. trade authorities to probe some imported sleep disorder systems”
September 19, 2016
From the article: “In a statement on Monday, the ITC said the probe would investigate products by New Zealand-based Fisher & Paykel Healthcare Corp Ltd and two of its U.S. units in California.”
Takeaway: Not a lot of reportage on this one yet, so this is more of an FYI and “stay tuned.”
“FDA Requires Strong Warnings for Benzodiazepine Labeling”
September 2, 2016
From the article: “After an extensive review of the latest scientific evidence, the US Food and Drug Administration (FDA) is requiring class-wide changes to drug labeling, including patient information, to help inform health care providers and patients of the serious risks associated with the combined use of certain opioid medications and a class of central nervous system (CNS) depressant drugs called benzodiazepines.”
Takeaway: The opioid epidemic continues to be examined in specific ways. For our purposes, right now is a good time to be especially cognizant of patient medication lists and to know the generic and biological names of the most common opioids and benzodiazepines so you can be wary of any potential combinations that might be worth flagging for review by an MD.
HEALTH LITERACY WATCH
“Simple computer model sheds light on sleeping brain”
MEDICAL NEWS TODAY
September 2, 2016
From the article: “Sleep science has progressed in leaps and bounds over recent decades. However, many difficult questions remain unanswered and its function is far from fully understood. Recent research gives new insight into sleep's memory processing capabilities.”
Takeaway: If we want a health literate nation, we have to start with ensuring our medical professionals are on top of the latest research. Here’s the latest inquiry into the age-old question, “Why do we sleep?” which sheds new light on this complicated body process.
“DoT Refreshes Rule Book to Include Self-Driving Cars”
TECH NEWS WORLD
September 20, 2016
From the article: “ ‘Driverless cars have the potential to eliminate drunk, drugged and drowsy driving," Sheehey-Church said. ‘A fully autonomous vehicle would stop a drunk or drugged driver simply because they can't physically drive the vehicle.’ ”
Takeaway: Sleep deprivation and sleep driving aren’t going to go away any time soon, unfortunately. This is one way American business is capitalizing on the national sleep debt.
BIO: Tamara Kaye Sellman RPSGT, CCSH curates the sleep news clearinghouse, SleepyHeadCENTRAL, where she follows sleep health headlines daily. She is also
Chief Content Officer for inboundMed and contributes as a freelance writer to
AAST’s magazine, A2Zzz, and other places.